Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Being Present-MPN: A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs and CML on Tyrosine Kinase Inhibitors

NCT04605211 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT04605211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04605211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Being Present-MPN: A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs and CML on Tyrosine Kinase Inhibitors
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Completed
Start date
September 18, 2020
Completion date
September 30, 2022
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia, chronic phase chronic myelogenous leukemia, myeloproliferative neoplasm